Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Federico Pérez Manghi

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care

English

Related publications

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

English

Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program

Diabetes/Metabolism Research and Reviews

English

Comparative Efficacy of Glimepiride and Metformin in Monotherapy of Type 2 Diabetes Mellitus: Meta-Analysis of Randomized Controlled Trials

Diabetology and Metabolic Syndrome

English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice

English

Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial

Diabetes, Obesity and Metabolism

English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism

2018

English

Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial

The Lancet Diabetes and Endocrinology

English

Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial

The Lancet Diabetes and Endocrinology

English

Walking Away From Type 2 Diabetes: A Cluster Randomized Controlled Trial

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Federico Pérez Manghi

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Related publications

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program

Comparative Efficacy of Glimepiride and Metformin in Monotherapy of Type 2 Diabetes Mellitus: Meta-Analysis of Randomized Controlled Trials

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial

Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial

Walking Away From Type 2 Diabetes: A Cluster Randomized Controlled Trial